Showing all 6 results
Atenolol & Chlorthalidone Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets. The combination is engineered to maintain therapeutic plasma levels over a 24-hour period, supporting once-daily dosing.
Active Ingredient Strength (Standard) Therapeutic Role Atenolol BP/USP 50 mg / 100 mg Cardioselective Beta-Blocker Chlorthalidone BP/USP 12.5 mg / 25 mg Long-acting Diuretic Excipients Q.S. Magnesium Stearate / Povidone Stabilizing Core Matrix Lamotrigine Tablets
FreeProduct Composition & Available Strengths
Because Lamotrigine demands highly delicate, low-dose introductory titration to ensure patient dermatological safety, we manufacture the full compendial strength matrix.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Lamotrigine USP / BP / IP 25 mg Oral Solid Uncoated / Dispersible Tablet Dermatological Intro Titration: Mandatory low-dose baseline format utilized exclusively for the critical initial 2-week dose-escalation phase. Lamotrigine USP / BP / IP 50 mg Oral Solid Uncoated / Dispersible Tablet Intermediate Step-Up Dosing: Step-up strength calibrated for weeks 3 and 4 of therapy to safely approach steady-state plasma metrics. Lamotrigine USP / BP / IP 100 mg Oral Solid Compressed Tablet Standard Maintenance Block: First-line international standard strength for adult maintenance monotherapy in epilepsy and bipolar stabilization. Lamotrigine USP / BP / IP 200 mg Oral High-Potency Solid Tablet Maximal Saturation Maintenance: High-strength configuration calibrated for advanced refractory partial seizures and combination therapies.






